Prior to the launch of the common market of medicines on the territory of the EAEU member states, a unique round table for the regulators and the pharmaceutical industry, the “International experience of the creation of a regional market of medicines” (experience and example of the European Union & Eurasian Economic Union), was held in Moscow. The Eurasian Economic Commission (EEC), the Association of International Pharmaceutical Manufacturers (AIPM), and the European Federation of Pharmaceutical Industries and Associations (EFPIA) were co-organizers of the event.
The opening ceremony was held with participation of Olga Kazanskaya, Vice-Governor of Saint Petersburg, Marc de Garidel, Chairman of Board and Chief Executive Officer of IPSEN, David Panikashvili, President of Pharmaceutical Group ROSTA, Marina Veldanova, Head of representative office of IPSEN in Russia, Vladimir Shipkov, Executive Manager of Association of International Pharmaceutical Manufacturers (AIPM), Jean-Maurice Ripert, Ambassador of France in Russia and recognized experts of pharmaceutical sector.
International pharmaceutical industry considers it necessary to maintain long-term strategic priorities of the state during implementation of the anti-crisis plan
April 14, 2015 – Association of international pharmaceutical manufacturers (AIPM) announces extension to its member list. The decision to include two new companies – Angelini and Glenmark, was made during AIPM General Managers Meeting.
The Associations discussed the specifics of the distribution of non-prescription drugs, as well as the implementation of the concept of responsible self-medication in Russia February 16, 2015 - The Board of Directors of the Association of the European Self-Medication Industry (AESGP) and AESGP Working Group on the Development of OTC-Market in Russia meetings were held in Moscow for the first time.
The first book written for public at large about medicines has been presented in Moscow. The authors, brought together by Vladislav Dorofeev, a well-known journalist and writer, collected facts and wrote their stories of the inventions and discoveries of ether and aspirin, haloperidol and smallpox vaccine, penicillin and Prozac, Viagra and Herceptin, hydrocortisone and cocaine, Losec and vitamins, insulin and lidocaine, and many others. By telling all these stories in an entertaining way, and invariably keeping true to the facts, the authors were not only able to take readers on a fascinating journey into the history and the present day of the drugs in our medicine box, but also provided an insight into pharmacy.
Representatives of international pharmaceutical industry shared their vision towards the solutions of key problems of the Russian pharmaceutical market and discussed the most important priorities for its further development.
June 17, 2014, St. Petersburg — As part of the 20th Russian Pharmaceutical Forum, the Association of International Pharmaceutical Manufacturers (AIPM), which is also celebrating its 20th anniversary this year, has initiated a discussion of the most pressing issues for today's pharmaceutical market, including the prospects for development of healthcarein the Russian Federation, increasing the innovative potential of local pharmaceutical industry, improving the regulatory system, building a modern drug provision system, etc.
March 28, 2014, Moscow – Association of International Pharmaceutical Manufacturers (AIPM) announces extension of the member list. On March 26, 2014 during the General Meeting of AIPM members it was decided that international pharmaceutical company Allergan join the Association.
The Association of International Pharmaceutical Manufacturers (AIPM) together with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released the findings of an analytical research on corporate healthy lifestyle practices at Russian and global companies and provide recommendations on the development and implementation of such programs.
Five global healthcare organizations have established a Consensus Framework for Ethical Collaboration to support partnerships that will aim to deliver greater patient benefits and support high quality patient care. Derived from the individual codes of ethical practice and health policy positions of the five supporting organizations, this framework is based on four overarching principles:
23 January 2014, Moscow – Association of International Pharmaceutical Manufacturers (AIPM) announces that Mrs. Naira Adamian, Managing Director of Pharma division of “Johnson and Johnson” Russia & CIS, has been appointed the Chairman of the Board of Directors
December 13, 2013, Moscow - The Association of International Pharmaceutical Manufacturers (AIPM) announces extension of the member list. On December 4, 2013 during the General Meeting of AIPM members it was decided that international pharmaceutical companies Alexion, Ferring Pharmaceuticals and Gilead Sciences join the Association.
Moscow, May 16,2013. Today several countries have regulatory requirements in place for the development and evaluation of biotherapeutic and biosimilar medicines. The European Union, for example, provides unified standards and guidelines that are effective in the entire region. In Russia, on the contrary, these topics are not yet regulated. This is one of the key points that international and Russian experts are discussing in the context of the two-day workshop Biotherapeutic Medicines – Regulatory Challenges and Current Practices. Approaches for Harmonization.
April 1, 2013, Moscow – The Association of International Pharmaceutical Manufacturers announces extension of the Association member list. On March 27, 2013 the General Meeting of AIPM members decided on the membership of R-Pharm Group. It is an important achievement for the Russian pharmaceutical market confirming the inconvertibility of partnership between Russian and international pharmaceutical companies and their further integration.
Draft documents limiting the state purchases of foreign medication do not take into account the Russian Federation citizens’ rights for affordable and high-quality treatment. It has been announced by the participants of the press conference devoted to the discussion on the draft RF Government Decree “On introducing additional requirements to order placement participants in case of placing orders for the provision of medications" and draft Law prepared by the Ministry of Industry and Trade of Russia and devoted to the criteria in accordance to which medications can be attributed to medicinal products of the Russian origin.
The world-famous Prix Galien Prize, created in France in 1970, is the most prestigious prize in biotechnologies and the pharmaceutical industry, which is annually awarded for outstanding achievements in the development of innovative treatment methods and technologies. The Galien Foundation has now decided to include Russia in the list of host countries for the competition, beginning from 2013.
25 April 2012, Moscow. – The Institute of Legislation and Comparative Law under the Government of the Russian Federation presented Legal Opinion on the topic ‘Legal Aspects of Interaction between Pharmaceutical Company Representatives and Healthcare Professionals’. This Legal Opinion was prepared with the support of the Association of International Pharmaceutical Manufacturers (AIPM).
On March 19, 2012, Pharmatsevtichenskiy vestnik (Pharmaceutical bulletin) newspaper and “Pharmexpert” Market Research Centre announced the most influential entities of the Russian pharmaceutical market in 2011. The annual review, which has been conducted more than 10 years, surveys independent market experts across various areas to rank influence in the Russian healthcare industry. Based on the answers provided by peers and industry experts, AIPM was named the Most Influential Non-Profit and Public Association by a wide margin.
All over the world February, 29 was marked as International Rare Disease Day - when the organizations active in the field of rare diseases and their partners join forces to raise awareness of society on problems of millions of people living with orphan diseases. Association of International Pharmaceutical Manufacturers (AIPM) partners with the international non-governmental patient-driven alliance EURORDIS and contributes to the communication to the Russian patients, doctors, and other stakeholders with the Russian version of web resource www.eurordis.org/ru